FOATE DEAN A

Director Dean Foate sells 10,000 PLXS shares at $205.00; stock near 52-week high ($208.36) after +40.9% 90-day surge

Director Foate sold 10,000 shares (-9.1% of pre-transaction holdings) at $205.00 on 2026-02-06, just days after a prior sale on 2026-02-02. The stock is currently trading at $206.00, near its 52-week high of $208.36, having surged +40.9% over 90 days and +30.6% over 30 days—significantly outpacing the insider's cross-ticker track record, which shows an average 90-day return of -16.2% following his prior sales. Notably, at this specific ticker (PLXS), the insider's prior three measurable sales (November 2024) all preceded declines of approximately 15-16% by the 90-day mark, achieving a 100% well-timed rate at this ticker. The current sale occurs during the stock's strongest momentum period, following a steep rally from a 52-week low of $110.95, which contrasts sharply with his historical pattern of selling ahead of downturns.

Director FOATE DEAN A sold 5,000 shares of PLXS at $204.89 on 2026-02-02 (near 52-week high); prior 3 sales well-timed with 90d declines.

FOATE DEAN A sold 5,000 shares at $204.89, which represents -4.2% from the 52-week high of $204.96 and occurs during a strong recent rally (+27.7% in 30 days, +36.8% in 90 days). The director retains 109,429 shares post-transaction. His cross-ticker track record shows a 100.00% well-timed rate across 3 prior sells (avg 90d return -16.2%), and his same-ticker history at PLXS demonstrates all 3 prior sales were well-timed at the 90-day mark with negative returns (-0.8%, -1.2%, -1.9% at 30 days and -16.4%, -15.8%, -16.4% at 90 days). The sale near the 52-week high, following a period of significant appreciation, combined with a consistent pattern of selling at inflection points, warrants investor attention to whether this marks a shift in momentum for the stock.

Director Dean A. Foate sold 10,000 shares at blended $163.84 for $1.6M; holds 106.1K shares post-sale.

Dean A. Foate, a Director at Plexus Corp, executed 3 separate sales totaling 10,000 shares on 2024-11-25 and 2024-11-26 for $1,638,384.60. The sales occurred at transaction prices ranging from $163.04 to $164.20, very close to the current price of $164.54 and near the 52-week high of $166.77. Following the sales, Foate retains 106,080 shares, representing an 8.6% reduction in his position. The stock has appreciated 16.5% over the prior 30 days and 29.3% over 90 days, placing it near its annual peak; simultaneously, the company reports a high P/E of 53.42 and negative annual revenue growth of -5.6%, suggesting a valuation disconnect with underlying fundamentals. The timing of the sale at elevated prices, combined with the fundamental weakness and high valuation multiple, warrants monitoring of director positioning relative to company performance trajectories.